Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNovaBridge Biosciences. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.76 | -$0.76 | -$0.76 |
| Q2 2026 | 1 | -$0.81 | -$0.81 | -$0.81 |
| Q3 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2026 | 1 | -$0.81 | -$0.81 | -$0.81 |
NovaBridge Biosciences. Earnings Date And Information
NovaBridge Biosciences. last posted its earnings results on Tuesday, April 7th, 2026. The company reported $-0.22 earnings per share for the quarter, missing analysts' consensus estimates of $-0.035 by $0.185. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NovaBridge Biosciences. has generated $0 earnings per share over the last year ($-0.16 diluted earnings per share) and currently has a price-to-earnings ratio of -17.65. NovaBridge Biosciences. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
NovaBridge Biosciences. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/07/2026 | Q4 2025 | -$0.04 | -$0.09 | -0.05 | $0 | $0 |
| 12/18/2025 | Q3 2025 | -$0.01 | -$0.16 | -0.15 | $0 | $0 |
| 08/20/2025 | Q2 2025 | N/A | -$0.07 | N/A | $0 | $0 |
| 04/03/2025 | Q1 2025 | N/A | -$0.28 | N/A | N/A | $0 |
| 04/03/2025 | Q4 2024 | N/A | -$0.11 | N/A | $10.95 M | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.25 | N/A | $10.53 M | $0 |
| 06/29/2024 | Q2 2024 | N/A | $0.30 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.21 | N/A | N/A | $0 |
| 10/31/2025 | Q4 2023 | N/A | -$4.16 | N/A | N/A | $1.14 M |
| 09/29/2023 | Q3 2023 | N/A | -$4.16 | N/A | N/A | $1.17 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.74 | N/A | N/A | $9.83 M |
| 05/01/2023 | Q1 2023 | N/A | -$4.65 | N/A | N/A | $9.83 M |
| 05/01/2023 | Q4 2022 | N/A | -$8.81 | N/A | N/A | $574.53 M |
| 09/29/2022 | Q3 2022 | N/A | -$8.81 | N/A | N/A | $-136,710,500 |
| 11/10/2022 | Q2 2022 | N/A | -$6.37 | N/A | N/A | $25.93 M |
| 03/31/2022 | Q1 2022 | N/A | -$6.37 | N/A | N/A | $25.93 M |
| 03/29/2022 | Q4 2021 | -$0.34 | -$8.00 | -7.66 | N/A | $35.13 M |
| 11/12/2021 | Q3 2021 | N/A | -$8.00 | N/A | N/A | $35.13 M |
| 06/30/2021 | Q2 2021 | N/A | -$7.34 | N/A | N/A | $8.89 M |
| 03/30/2021 | Q1 2021 | N/A | -$7.34 | N/A | N/A | $8.89 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NovaBridge Biosciences. Earnings: FAQ's
The conference call for NovaBridge Biosciences.'s latest earnings report can be listened to online.
The conference call transcript for NovaBridge Biosciences.'s latest earnings report can be read online.
NovaBridge Biosciences. (:NBP) has a recorded net income of $-6,614,616.NovaBridge Biosciences. has generated $-0.16 earnings per share over the last four quarters.
NovaBridge Biosciences. (:NBP) has a price-to-earnings ratio of -17.65 and price/earnings-to-growth ratio is 0.17.